Pharma & Bio
Technology
All 8 Pharmaceutical and Biotech Companies Listed This Year Traded Below Their Offering Price… Will IPOs in the Second Half Also See Lower Valuations?
The stock prices of all eight pharmaceutical, biotech, and healthcare companies that listed on KOSDAQ this year are trading below their initial public offering (IPO) prices. Although these companies r…
Technology
[K-Bio Fund, Part 2] CEO Hwang Man-soon, Who Leads the Phase 3 Clinical Trial Fund: "Aiming for First Investment This Year… Focus on Rare Disease Pipeline"
“We expect to complete the formation of the fund during the fourth quarter and make our first investment by the end of the year. We’ve been receiving inquiries from various sources ever since the asse…
Technology
[K-Bio Fund, Part 1] From the National Growth Fund to a 1 Trillion Mega Fund… The Government Fills the 'Death Valley'
Government policy funds are being channeled through a two-track approach to address the late-stage clinical funding gap, which has been the biggest challenge facing the domestic pharmaceutical and bio…
Technology
A Closer Look at U.S. CPT Code Requirements… Raises Questions About Rokit Healthcare’s Potential to Benefit
(Graphic: ChatGPT)
While Rokit Healthcare expects to benefit from the reorganization of U.S. medical procedure codes related to regenerative medicine, a closer look at the detailed requirements of…
Technology
Biotech Stocks Rally as the Market Rebounds; Orum Therapeutics Jumps 18% [K-Bio Pulse]
On July 31, South Korean pharmaceutical and biotech stocks rose across the board as the domestic stock market rebounded, with bargain hunting returning to battered growth and biotech stocks. While man…
Technology
Biotech Stocks Rise Along with Stock Market Rebound… Orum Therapeutics, Inc. Soars 18% [Biotech Spotlight]
On the 31st, domestic pharmaceutical and biotech stocks showed a broadly strong performance, buoyed by a market rebound. Although there were quite a few stocks without any clear individual catalysts, …
Technology
Deciding the Outcome Outside the Lab… RA and BD: The “Highly Sought-After” Professionals in the Pharmaceutical and Biotech Sectors
(Graphic: ChatGPT)
When it comes to the workforce that determines the competitiveness of pharmaceutical and biotech companies, researchers are cited as the most critical. This is because new dru…
Lifestyle
[The Biomarker Money Game] “Liquid Biopsy,” Essential for Precision Medicine, Also Used in New Drug Development… Commercial Potential on the Rise
Liquid biopsy—a method of diagnosing cancer using only bodily fluids such as blood—has established itself as an essential technology in precision medicine and is expanding its scope of application to …
Technology
SkyLabs Aims for KOSDAQ… The Global Bidding War for K-Bio Contracts Unfolds in Seoul [Bio Monthly Roundup]
(Graphic: E-Daily Reporter Kim Jeong-hoon)
In August, the major events in South Korea’s pharmaceutical and biotech industry include the KOSDAQ listing of digital healthcare company SkyLabs and a s…
Technology
Targeting Niche Markets in U.S. Big Tech… A Look at K-SleepTech Companies Aiming for Precision Diagnostics
"Sleep accounts for one-third of our lives. Sleep diagnostics, which were previously only available in hospitals, are now coming into our bedrooms."As noted by Yoon In-young, a professor in the Depart…